A new look at osteoporosis outcomes: the influence of treatment, compliance, persistence, and adherence
- PMID: 16901022
- DOI: 10.4065/81.8.1009
A new look at osteoporosis outcomes: the influence of treatment, compliance, persistence, and adherence
Comment on
-
Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases.Mayo Clin Proc. 2006 Aug;81(8):1013-22. doi: 10.4065/81.8.1013. Mayo Clin Proc. 2006. PMID: 16901023
Similar articles
-
Adherence and persistence: impact on outcomes and health care resources.Bone. 2006 Feb;38(2 Suppl 2):S18-21. doi: 10.1016/j.bone.2005.11.013. Epub 2006 Jan 27. Bone. 2006. PMID: 16443406 Review.
-
How to prevent glucocorticoid-induced osteoporosis.Cleve Clin J Med. 2010 Aug;77(8):529-36. doi: 10.3949/ccjm.77a.10003. Cleve Clin J Med. 2010. PMID: 20682515 Review.
-
The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis.Expert Rev Pharmacoecon Outcomes Res. 2012 Apr;12(2):159-66. doi: 10.1586/erp.12.8. Expert Rev Pharmacoecon Outcomes Res. 2012. PMID: 22458617 Review.
-
Persistence with bisphosphonate treatment for osteoporosis: finding the root of the problem.Am J Med. 2006 Apr;119(4 Suppl 1):S12-7. doi: 10.1016/j.amjmed.2005.12.018. Am J Med. 2006. PMID: 16563936 Review.
-
How can osteoporosis patients benefit more from their therapy? Adherence issues with bisphosphonate therapy.Ann Pharmacother. 2006 Jun;40(6):1143-50. doi: 10.1345/aph.1G534. Epub 2006 May 30. Ann Pharmacother. 2006. PMID: 16735667 Review.
Cited by
-
Adherence to alendronate in male veterans.Osteoporos Int. 2008 Mar;19(3):349-56. doi: 10.1007/s00198-007-0471-4. Epub 2007 Sep 26. Osteoporos Int. 2008. PMID: 17898921
-
Analysis of Influencing Factors of Medication Compliance in Patients with Recurrent Vertebral Fractures after Percutaneous Kyphoplasty and the Role of Family-Centered Education Intervention.Evid Based Complement Alternat Med. 2021 Oct 22;2021:3974674. doi: 10.1155/2021/3974674. eCollection 2021. Evid Based Complement Alternat Med. 2021. Retraction in: Evid Based Complement Alternat Med. 2023 Sep 27;2023:9793706. doi: 10.1155/2023/9793706. PMID: 34721630 Free PMC article. Retracted.
-
Evaluating adherence, tolerability and safety of oral calcium citrate in elderly osteopenic subjects: a real-life non-interventional, prospective, multicenter study.Aging Clin Exp Res. 2024 Feb 12;36(1):38. doi: 10.1007/s40520-024-02696-9. Aging Clin Exp Res. 2024. PMID: 38345765 Free PMC article.
-
Denosumab: a review of its use in postmenopausal women with osteoporosis.Drugs Aging. 2014 Jul;31(7):555-76. doi: 10.1007/s40266-014-0191-3. Drugs Aging. 2014. PMID: 24935243 Review.
-
Cost-effective osteoporosis treatment thresholds: the United States perspective.Osteoporos Int. 2008 Apr;19(4):437-47. doi: 10.1007/s00198-007-0550-6. Epub 2008 Feb 22. Osteoporos Int. 2008. PMID: 18292976 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical